KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organon (OGN) Capital Expenditures (2020 - 2025)

Organon (OGN) has 6 years of Capital Expenditures data on record, last reported at $45.0 million in Q4 2025.

  • For Q4 2025, Capital Expenditures fell 18.18% year-over-year to $45.0 million; the TTM value through Dec 2025 reached $162.0 million, down 7.43%, while the annual FY2025 figure was $162.0 million, 7.43% down from the prior year.
  • Capital Expenditures reached $45.0 million in Q4 2025 per OGN's latest filing, down from $46.0 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $79.0 million in Q4 2023 and bottomed at $32.0 million in Q2 2024.
  • Average Capital Expenditures over 5 years is $48.8 million, with a median of $46.0 million recorded in 2023.
  • Peak YoY movement for Capital Expenditures: soared 57.78% in 2023, then tumbled 54.93% in 2024.
  • A 5-year view of Capital Expenditures shows it stood at $59.0 million in 2021, then rose by 6.78% to $63.0 million in 2022, then increased by 25.4% to $79.0 million in 2023, then plummeted by 30.38% to $55.0 million in 2024, then decreased by 18.18% to $45.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Capital Expenditures were $45.0 million in Q4 2025, $46.0 million in Q3 2025, and $39.0 million in Q2 2025.